BMKDF

BioMark Diagnostics Inc.

USOTC

Add Alert

BMKDF

BioMark Diagnostics Inc.

USOTC

Add Alert

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating

MERCURIAL

06/11/20 4:56 PM

Post #26

Re: #24: @MADDSTACKER - I’m so alone .. can anyone hear me

I hear you. Loading :)

MADDSTACKER Free

06/11/20 9:57 AM

Post #25

Covid and lung cancer screening this going to dollars imho ...

MADDSTACKER Free

06/10/20 9:57 AM

Post #24

I’m so alone .. can anyone hear me .. bawhahahaha

MADDSTACKER Free

06/10/20 9:34 AM

Post #23

Covid test kits , in talks with government ,, 2 weeks expect a roll out ....

STOCKPICKER4LIFE PremiumMember

05/13/17 4:04 AM

Post #22

ronpopeil

12/29/16 10:22 PM

Post #21

Re: #19: @MichaelVest - BioMark raw data collection complete on 200 patient

Does anyone follow this company anymore?

Bing420

10/18/16 11:17 AM

Post #20

Soooo...any reason for the tanking in the last day?

MichaelVest Free

07/28/16 8:42 PM

Post #19

BioMark raw data collection complete on 200 patient trial. Data will be reviewed then compiled into a report. Trial met both Health Canada and U.S. FDA standards.

Complete article below:

Data Collection

MichaelVest Free

04/02/16 7:25 PM

Post #18

Expect commercializing of BioMark's early detection red alert technology. Looking like 2016 will be a big year for BioMark!!!

MichaelVest Free

04/02/16 7:23 PM

Post #17

BioMark receives approval from Health Canada and the Ethics Review Board for their lung cancer protocol, and will now start pilot study at CancerCare Manitoba in April.

Full article here: Lung Cancer Protocol

MichaelVest Free

03/08/16 7:18 PM

Post #16

Great Video BioMark Cancer Survivorship Program

Cancer Survivorship Program

MichaelVest Free

03/08/16 7:12 PM

Post #15

A good article regarding BioMark

A Good Choice For MMJ and Biotech Market Opportunity

MichaelVest Free

03/08/16 7:09 PM

Post #14

BioMark Announces Progress

[url][/url][tag]Progress with Assayhttp://www.biomarkdiagnostics.com/investor-relations/investment-highlights/news-releases/[/tag]

MichaelVest Free

10/04/15 7:54 PM

Post #12

Quest for Game Changing Lung Cancer Diagnostic Assay Video

MichaelVest Free

10/04/15 7:35 PM

Post #11

BioMark expects to begin study of its' assay in 4th quarter of 2015

Begin assay study in 4th quarter

MichaelVest Free

10/04/15 7:31 PM

Post #10

BioMark receives clearance from Health Canada to commence clinical trial of their assay.

Health Canada clearance

MichaelVest Free

08/27/15 11:53 AM

Post #9

Interim financial report June 2015

Fin. report

MichaelVest Free

08/27/15 11:49 AM

Post #8

Dr. Thomas Malcolm to head U.S. operations. Brings experience to U.S. strategy.

Ph.D in molecular biology and biochemistry, and a post doctoral fellow for both Mount Sinai School of Medicine and Memorial Sloan Kettering Cancer Center.

MichaelVest Free

08/27/15 11:43 AM

Post #7

BioMark lays out plan for U.S.

Going to be based in Maryland, appointed head of U.S. operations, planning on gaining approval from Health Canada in 2016, then FDA approval to follow.

U.S. Strategy

MichaelVest Free

08/27/15 11:29 AM

Post #6

BioMark is four weeks out with data on their assay cancer test. Look to be meeting all requirements for FDA.

Press release here

MichaelVest Free

06/16/15 10:07 PM

Post #5

Two patent applications for BioMark below:

Monoclonal Antibody

and

Method for Assaying

MichaelVest Free

06/16/15 9:00 PM

Post #4

Company currently holds patent for their tech. Patent number 6811967 Link below for full patent information:

Full patent info

MichaelVest Free

06/16/15 8:03 PM

Post #3

From Nov. 2014 but good information on what the company is trying to do.

BioMark Diagnostics Info

GoBison

03/02/15 10:00 AM

Post #2

Anyone trading this yet?

jupp

03/02/15 9:07 AM

Post #1

BioMark Announces Grant Funded Partnership With TMIC

www.fscwire.com/newsrelease/biomark-announces-grant-funded-partnership-tmic

BioMark Brings New Life to Cancer Detection Technology

www.biomarkdiagnostics.com/biomark-brings-new-life-to-cancer-detection-technology/

BioMark Announces Private Placement

www.fscwire.com/newsrelease/biomark-announces-private-placement

BioMark Diagnostics Inc. (BMKDF)

Followers	1	Posters	8
Posts (Today)	0	Posts (Total)	26
Created	01/21/15	Type	Free
Moderators

BioMark is a Canadian based biotech company developing a metabolic based diagnostic assay that will allow early cancer detection. BioMark currently holds a number of patents for their technology (patent no. 6811967, and patent applications for Monoclonal antibodies, and Method of Assay).

Their test uses a drug called Amantadine which is given to patients prior to analysis of their urine. The drug is acetylated using using the enzyme Spermine/Spermidine N-Acetyl Transferase (SSAT) which has been found in many cancers including lung, breast, melonomas, and GI. This method will allow for earlier detection of these cancers while minimizing costs.

Recent interview with Rahsheed Ahmed on SNN

EXECUTIVE TEAM & ADVISORS

Research/Scientific/Clinical

Dr. Daniel S. Sitar – Principal Scientific Advisor/Consultant
Dr. John Yoo – Clinical Oncologist – Co-Chair CancerCare Ontario Head and Neck; Professor Dept. of Oncology Schulich School of Medicine & Dentistry, Western Ontario
Dr. John Schrader – Antibody development – Chair of Biomedical, Research Centre at University of British Columbia
Dr. Horacio Bach – Antibody Engineering UBC
Dr. Safieddin Safavi-Naeini – NSERC/BlackBerry Industrial Research Chair at University of Waterloo

Media Advisory Board

Bill Good – Veteran Broadcaster, Honorary Doctorate of Technology from BCIT

Regulatory

Dr. Ramjiawan from SBRC – Clinical Trial and Regulatory Expertise

Downstream

Jim Elliott – Downstream Technology Advisor and QMS support

North American Management

Rashid Ahmed – Founder, Chief Executive Officer
Dr. Thomas Malcolm – President & Chief Scientific Officer
Brian Cheng – Chief Technical Officer
Abbey Abdiye – Chief Financial Officer (Canada)
Neal Kaplan – Chief Financial Officer (US)
Dr. Kenneth Kohn – Patent Attorney
Gina Huang – Project Director

Medical Delivery Panel

Dr. James Bond – Chief of Thoracic Surgeon Surrey Hospital
Dr. Dwight De Risi – Breast Oncology Surgeon
Dr. Debra Hoffman – Lung Oncology Surgeon

Supporting

Dr. Reuven Gordon and Dr. Fraser Hof Canadian Research Chairs, Uvic
Dr. Andrew Maksymiuk University of Manitoba and Manitoba CancerCare
Dr. Samudra Dissanyake – Scientific Advisor business development
Stan Lee – Chartered Accountant